Zusammenfassung
Pharmakologische Wirkstoffe, die den Effekt des Azetylcholins am cholinergen Rezeptor nachahmen, werden allgemein als Parasympathomimetika, cholinerge Agonisten oder Miotika bezeichnet, wobei letzterer Terminus der gemeinsamen pupillenverengenden Wirkung dieser Substanzgruppe Rechnung trägt. Die Parasympathomimetika waren die ersten Antiglaukomatosa, die etwa 1870 in die Glaukomtherapie eingeführt wurden. Alle Vertreter dieser Wirkstoffklasse haben die gleiche prinzipielle Wirkung auf die Kammerwasserdynamik und ihre wesentlichen Unterschiede bestehen in der Wirkungsdauer sowie in der Schwere der Nebenwirkungen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Mindel, JS, Kharlamb, AB: Alteration of acetylcholine synthesis by pilocarpine. Arch Ophthal 102:1546, 1984.
Armaly, MF, Jepson, NC: Accommodation and the dynamics of the steady-state intraocular pressure. Invest Ophthal 1:480, 1952.
Van Buskirk, EM, Grant, WM: Lens depression and aqueous outflow in enucleated primate eyes. Am J Ophthal 76:632, 1973.
Van Buskirk, EM: Changes in the facility of aqueous outflow induced by lens depression and intraocular pressure in excised human eyes. Am J Ophthal 82:736, 1978.
Van Buskirk, EM: The canine eye: lens depression and aqueous outflow. Invest Ophthal Vis Sci 19:789, 1980.
Moses, RA, Grodzki, WJ Jr: Choroid tension and facility of aqueous outflow. Invest Ophthal Vis Sci 16:1062,1977.
Cairns, JE: Goniospasis: a method designed to relieve canicular blockade in primary open-angle glaucoma. Ann Ophthal 8:1417, 1976.
Kaufman, PL, Bárány, EH: Residual pilocarpine effects on outflow facility after ciliary muscle disinsertion in the cynomolgus monkey. Invest Ophthal 15:558, 1976.
Kaufman, PL, Bárány, EH: Loss of acute pilocarpine effect on outflow facility following surgical disinsertion and retro-displacement of the ciliary muscle from the scleral spur in the cynomolgus monkey. Invest Ophthal 15:793, 1976.
Kaufman, PL, Bill, A, Bárány, EH: Formation and drainage of aqueous humor following iris removal and ciliary muscle disinsertion in the cynomolgus monkey. Invest Ophthal Vis Sci 16:226, 1977.
Lütjen-Drecoll, E, Kaufman, PL, Bárány, EH: Light and electron microscopy of the anterior chamber angle structures following surgical disinsertion of the ciliary muscle in the cynomolgus monkey. Invest Ophthal Vis Sci 16:218, 1977.
Grierson, I, Lee, WR, Abraham, S: Effects of pilocarpine on the morphology of the human outflow apparatus. Br J Ophthal 62:302, 1978.
Grierson, I, Lee, WR, Moseley, H, Abraham, S: The trabecular wall of Schlemm’s canal: a study of the effects of pilocarpine by scanning electron microscopy. Br J Ophthal 63:9, 1979.
Grierson, I, Lee, WR, Abraham, S: The effects of topical pilocarpine on the morphology of the outflow apparatus of the baboon (Papio cynocephalus). Invest Ophthal Vis Sci 18:346, 1979.
Lütjen-Drecoll, E, Tamm, E, Kaufman, PL: Age-related loss of morphologic responses to pilocarpine in Rhesus monkey ciliary muscle. Arch Ophthal 106:1591, 1988.
Erickson-Lamy, KA, Kaufman, PL: Reinnervation of primate ciliary muscle following ciliary ganglionectomy. Invest Ophthal Vis Sci 28:927, 1987.
Erickson-Lamy, KA, Kaufman, PL: Effect of cholinergic drugs on outflow facility after ciliary ganglionectomy. Invest Ophthal Vis Sci 29:491, 1988.
Suzuki, R, Oso, T, Kobayashi, S: Cholinergic inhibitory response in the bovine iris dilator muscle. Invest Ophthal Vis Sci 24:760, 1983.
Kaufman, PL: Aqueous humor dynamics following total iridectomy in the cynomolgus monkey. Invest Ophthal Vis Sci 18:870, 1979.
Gaasterland, D, Kupfer, C, Ross, K: Studies of aqueous humor dynamics in man. IV. Effects of pilocarpine upon measurements in young normal volunteers. Invest Ophthal 14:848, 1975.
Barsam, PC: Comparison of the effect of pilocarpine and echothiophate on intraocular pressure and outflow facility. Am J Ophthal 73:742, 1972.
Miichi, H, Nagataki, S: Effects of pilocarpine, salbutamol, and timolol in aqueous humor formation in cynomolgus monkeys. Invest Ophthal Vis Sci 24:1269, 1983.
Bárány, EH: A pharmacologist looks at medical treatment in glaucoma-in retrospect and in prospect. Ophthalmology 86:80, 1979.
Helbig, H, Korbmacher, C, Wohlfarth, J, et al: Effect of acetylcholine on membrane potential of cultured human nonpigmented ciliary epithelial cells. Invest Ophthal Vis Sci 30:890, 1989.
Jumblatt, JE, North, GT, Hackmiller, RC: Muscarinic cholinergic inhibition of adenylate cyclase in the rabbit iris-ciliary body and ciliary epithelium. Invest Ophthal Vis Sci 31:1103, 1990.
Nagataki, S, Brubaker, RF: Effect of pilocarpine on aqueous humor formation in human beings. Arch Ophthal 100:818, 1982.
Bill, A, Phillips, CI: Uveoscleral drainage of aqueous humour in human eyes. Exp Eye Res 12:275, 1971.
Bleiman, BS, Schwartz, AL: Paradoxical intraocular pressure response to pilocarpine. A proposed mechanism and treatment. Arch Ophthal 97:1305, 1979.
Doane, MB, Jensen, AD, Dohlman, CH: Penetration routes of topically applied eye medications. Am J Ophthal 85:383, 1978.
Sieg, JW, Robinson, JR: Mechanistic studies on transcorneal permeation of pilocarpine. J Pharm Sci 65:1816, 1976.
Van Hoose, MC, Leaders, FE: The role of the cornea in the biologic response to pilocarpine. Invest Ophthal 13:377, 1974.
Lazare, R, Horlington, M: Pilocarpine levels in the eyes of rabbits following topical application. Exp Eye Res 21:281, 1975.
Krohn, DL, Breitfeller, JM: Transcorneal flux of topical pilocarpine to the human aqueous. Am J Ophthal 87:50, 1979.
Asseff, CG, Weisman, RL, Podos, SM, Becker, B: Ocular penetration of pilocarpine in primates. Am J Ophthal 75:212, 1973.
Chrai, SS, Robinson, JR: Corneal permeation of topical pilocarpine nitrate in the rabbit. Am J Ophthal 77:735, 1974.
Harris, LS, Galin, MA: Dose response analysis of pilocarpine-induced ocular hypotension. Arch Ophthal 84:605, 2970.
Drance, SM, Nash, PA: The dose response of human intraocular pressure to pilocarpine. Can J Ophthal 6:9, 1971.
Drance, SM, Bensted, M, Schulzer, M: Pilocarpine and intraocular pressure. Duration of effectiveness of 4% and 8% pilocarpine instillation. Arch Ophthal 91:104, 1974.
Harris, LS: Comparison of pilocarpine and echothiophate iodide in open-angle glaucoma. Ann Ophthal 4:736, 1972.
Harris, LS, Galin, MA: Effect of ocular pigmentation of hypotensive response to pilocarpine. Am J Ophthal 72:923, 1971.
Lerman, S, Reininger, B: Simulated sustained release pilocarpine therapy and aqueous humor dynamics. Can J Ophthal 6:14, 1971.
Birmingham, AT, Galloway, NR, Walker, DA: Intraocular pressure reduction in chronic simple glaucoma by continuous infusion of dilute pilocarpine solution. Br J Ophthal 63:808, 1979.
Patton, TF, Francoeur, M: Ocular bioavailability and systemic loss of topically applied ophthalmic drugs. Am J Ophthal 85:225, 2978.
File, RR, Patton, TF: Topically applied pilocarpine. Human pupillary response as a function of drop size. Arch Ophthal 98:112, 1980.
Shell, JW: Ophthalmic drug delivery systems. Surv Ophthal 29:117, 1984.
Barsam, PC: The most commonly used miotic-now longer acting. Ann Ophthal 6:809, 1974.
Magder, H, Boyaner, D: The use of a longer acting pilocarpine in the management of chronic simple glaucoma. Can J Ophthal 9:285, 1974.
Sherman, SE: Clinical comparison of pilocarpine preparations in heavily pigmented eyes: an evaluation of the influence of polymer vehicles on corneal penetration, drug availability, and duration of hypotensive activity. Ann Ophthal 9:1231, 1977.
Quigley, HA, Pollack, IP: Intraocular pressure control with twice-daily pilocarpine in two vehicle solutions. Ann Ophthal 9:427, 1977.
Green, K, Downs, SJ: Ocular penetration of pilocarpine in rabbits. Arch Ophthal 93:1165, 1975.
Harbin, TS Jr, Kaback, MB, Podos, SM, Becker, B: Comparative intraocular pressure effects of Adsorbocarpine and Isoptocarpine. Ann Ophthal 10:59, 1978.
Ticho, U, Blumenthal, M, Zonis, S, et al: Piloplex, a new long-acting pilocarpine polymer salt. A: Long-term study. Br J Ophthal 63:45, 1979.
Mazor, Z, Ticho, U, Rehany, U, Rose, L: Piloplex, a new long-acting pilocarpine polymer salt. B: Comparative study of the visual effects of pilocarpine and Piloplex eye drops. Br J Ophthal 63:48, 1979.
Ticho, U, Blumenthal, M, Zonis, S, et al: A clinical trial with Piloplex-a new long-acting pilocarpine compound: preliminary report. Ann Ophthal 11:555, 1979.
Duzman, E, Quinn, CA, Warman, A, Warman, R: One-month crossover trial comparing the intraocular pressure control of 3.4% piloplex twice daily with 2.0% pilocarpine four times daily. Acta Ophthal 60:613, 1982.
Klein, HZ, Lugo, M, Shields, MB, et al: A dose-response study of piloplex for duration of action. Am J Ophthal 99:23, 1985.
March, WF, Stewart, RM, Mandell, Al, Bruce, LA: Duration of effect of pilocarpine gel. Arch Ophthal 100:1270, 1982.
Stewart, RH, Kimbrough, RL, Smith, JP, Ward, RL: Long acting pilocarpine gel: a dose-response in ocular hypertensive subjects. Glaucoma 6:182, 1984.
Goldberg, I, Ashburn, FS Jr, Kass, MA, Becker, B: Efficacy and patient acceptance of pilocarpine gel. Am J Ophthal 88:843, 1979.
Johnson, DH, Epstein, DL, Allen, RC, et al: A one-year multicenter clinical trial of pilocarpine gel. Am J Ophthal 97:723, 1984.
Krause, K, Kuchle, JH, Baumgart, M: Comparative investigations of pilocarpine gel and pilocarpine eye drops. Klin Monatsbl Augenheilkd 187:178, 1985.
Johnson, DH, Keyon, KR, Epstein, DL, Van Buskirk, EM: Corneal changes during pilocarpine gel therapy. Am J Ophthal 101:13, 1986.
Smith, SA, Smith, SE, Lazare, R: An increased effect of pilocarpine on the pupil by application of the drug in oil. Br J Ophthal 62:314, 1978.
Bhojwani, SC, Jones, DK: Comparative study of aqueous and oily pilocarpine in the production of ocular hypotension. Br J Ophthal 65:530, 1981.
Camber, O, Edman, P, Gurny, R: Influence of sodium hyaluronate on the miotic effect of pilocarpine in rabbits. Curr Eye Res 6:779, 1987.
Cheeks, L, Green, K, Stone, RP, Riedhammer, T: Comparative effects of pilocarpine in different vehicles on pupil diameter in albino rabbits and squirrel monkeys. Curr Eye Res 8:1251, 1989.
Diepold, R, Kreuter, J, Himber, J, et al: Comparison of different models for the testing of pilocarpine eyedrops using conventional eyedrops and a novel depot formulation (nanoparticles). Graefe’s Arch Ophthal 227:188, 1989.
Place, VA, Fisher, M, Herbst, S, et al: Comparative pharma-cologic effects of pilocarpine administered to normal subjects by eyedrops or by ocular therapeutic systems. Am J Ophthal 80:706, 1975.
Lee, P-F, Shen, Y-T, Eberle, M: The long-acting Ocusertpilocarpine system in the management of glaucoma. Invest Ophthal 14:43, 1975.
Quigley, HA, Pollack, IP, Harbin, TS Jr: Pilocarpine Ocuserts. Long-term clinical trials and selected pharmacodynamics. Arch Ophthal 93:771, 1975.
Armaly, MF, Ra, KR: The effect of pilocarpine Ocusert with different release rates on ocular pressure. Invest Ophthal 12:491, 1973.
Worthen, DM, Zimmerman, TJ, Wind, CA: An evaluation of the pilocarpine Ocusert. Invest Ophthal 13:296, 1974.
Drance, SM, Mitchell, DWA, Schultzer, M: The duration of action of pilocarpine Ocusert on intraocular pressure in man. Can J Ophthal 10:450, 1975.
Macoul, KL, Pavan-Langston, D: Pilocarpine Ocusert system for sustained control of ocular hypertension. Arch Ophthal 93:587, 1975.
Sendelbeck, L, Moore, D, Urquhart, J: Comparative distribution of pilocarpine in ocular tissues of the rabbit during administration by eyedrops or by membrane-controlled delivery systems. Am J Ophthal 80:274, 1975.
Brown, HS, Meltzer, G, Merrill, RC, et al: Visual effects of pilocarpine in glaucoma. Comparative study of administration by eyedrops or by ocular therapeutic systems. Arch Ophthal 94:1716, 1976.
Francois, J, Goes, F, Zagorski, Z: Comparative ultrasono-graphic study of the effect of pilocarpine 2% and Ocusert P20 on the eye components. Am J Ophthal 86:233, 1978.
Fruanfelder, FT, Shell, JW, Herbst, SF: Effect of pilocarpine ocular therapeutic systems on diurnal control of intraocular pressure. Ann Ophthal 8:1031, 1976.
Smith, SE, Smith, SA, Friedmann, Al, Chaston, JM: Comparison of the pupillary, refractive, and hypotensive effects of Ocusert-40 and pilocarpine eyedrops in the treatment of chronic simple glaucoma. Br J Ophthal 63:228, 1979.
Akerblom, T, Aurell, E, Cristiansson, J, et al: A multicentre study of the effect and tolerance of Ocusert-P-40. Acta Ophthal 58:617, 1980.
Bensinger, R, Shin, DH, Kass, MA, et al: Pilocarpine ocular inserts. Invest Ophthal 15:1008, 1976.
Maichuk, YF, Erichev, VP: Soluble ophthalmic drug inserts with pilocarpine: experimental and clinical study. Glaucoma 3:239, 1981.
Kelly, JA, Molyneux, PD, Smith, SA, Smith, SE: Relative bioavailability of pilocarpine from a novel ophthalmic delivery system and conventional eyedrop formulations. Br J Ophthal 73:360, 1989.
Krohn, DL, Breitfeller, JM: Quantitation of pilocarpine flux enhancement across isolated rabbit cornea by hydrogel polymer lenses. Invest Ophthal 14:152, 1975.
Ruben, M, Watkins, R: Pilocarpine dispensation for the soft hydrophilic contact lens. Br J Ophthal 59:455,1975.
Ramer, RM, Gasset, AR: Ocular penetration of pilocarpine: the effect of hydrophilic soft contact lenses on the ocular penetration of pilocarpine. Ann Ophthal 6:1325, 1974.
Podos, SM, Becker, B, Asseff, C, Hartstein, J: Pilocarpine therapy with soft contact lenses. Am J Ophthal 73:336, 1972.
Mehta, HK: Subconjunctival injection of pilocarpine. Trans Ophthal Soc UK 96:184, 1976.
Jay, JL, MacDonald, M: Effects of intraocular miotics on cultured bovine corneal endothelium. Br J Ophthal 62:815, 1978.
Kini, MM, Dahl, AA, Roberts, CR, et al: Echothiophate, pilocarpine, and open-angle glaucoma. Arch Ophthal 89:190, 1973.
Kaufman, PL, Bárány, EH: Subsensitivity to pilocarpine in primate ciliary muscle following topical anticholinesterase treatment. Invest Ophthal 14:302, 1975.
Kaufman, PL, Bárány, EH: Subsensitivity to pilocarpine of the aqueous outflow system in monkey eyes after topical anticholinesterase treatment. Am J Ophthal 82:883, 1976.
Kaufman, PL: Anticholinesterase-induced cholinergic subsensitivity in primate accommodative mechanism. Am J Ophthal 85:622, 1978.
Bito, LZ, Baroody, RA: Gradual changes in the sensitivity of rhesus monkey eyes to miotics and the dependence of these changes on the regimen of topical cholinesterase inhibitor treatment. Invest Ophthal Vis Sci 18:794, 1979.
Erickson-Lamy, KA, Polansky, JR, Kaufman, PL, Zlock, DM: Cholinergic drugs alter ciliary muscle response and receptor content. Invest Ophthal Vis Sci 28:375, 1987.
Bito, LZ, Mirritt, SQ: Paradoxical ocular hypertensive effect of pilocarpine on echothiophate iodide-treated primate eyes. Invest Ophthal Vis Sci 19:371, 1980.
Kronfeld, PC: The efficacy of combinations of ocular hypo-tensive drugs. A tonographic approach. Arch Ophthal 78:140, 1967.
Harris, LS, Mittag, TW, Galin, MA: Aqueous dynamics of pilocarpine-treated eyes. The influence of topically applied epinephrine. Arch Ophthal 86:1, 1971.
Knupp, JA, Shields, MB, Mandell, AI, et al: Combined timolol and epinephrine therapy for open-angle glaucoma. Surv Ophthal 28:280, 1983.
Duffey, RJ, Ferguson, JG: Interaction of dipivefrin and epinephrine with the pilocarpine ocular therapeutic system (Ocusert). Arch Ophthal 104:1135, 1986.
Söderström, MB, Wallin, Ö, Granström, P-A, Thorburn, W: Timolol-pilocarpine combined vs timolol and pilocarpine given separately. Am J Ophthal 107:465, 1989.
Airaksinen, PJ, Valkonen, R, Stenborg, T, et al: A double-masked study of timolol and pilocarpine combined. Am J Ophthal 104:587, 1987.
Maclure, GM, Vogel, R, Sturm, A, Binkowitz, B: Effect on the 24-hour diurnal curve of intraocular pressure of a fixed ratio combination of timolol 0.5% and pilocarpine 2% in patients with COAG not controlled on timolol 0.5%. Br J Ophthal 73:827, 1989.
Ellis, PP, Riegel, M: Influence of ophthalmic ointments on the penetration of pilocarpine drops. J Ocul Pharmacol 5:119, 1989.
Greco, JJ, Kelman, CD: Systemic pilocarpine toxicity in the treatment of angle closure glaucoma. Ann Ophthal 5:57, 1973.
Curti, PC, Renovanz, H-D: The effect of unintentional overdoses of pilocarpine on pulmonary surfactant in mice. Klin Monatsbl Augenheilkd 179:113, 1981.
Littman, L, Kempler, P, Rhola, M, Fenyvesi, T: Severe symptomatic atrioventricular block induced by pilocarpine eye drops. Arch Intern Med 147:586, 1987.
Reyes, PF, Dwyer, BA, Schwartzman, RJ, Sacchetti, T: Mental status changes induced by eye drops in dementia of the Alzheimer type. J Neurol Neurosurg Psych 50:113, 1987.
Granstrom, PA, Norell, S: Visual ability and drug regimen: relation to compliance with glaucoma therapy. Acta Ophthal 61:206, 1983.
Abramson, DH, Coleman, DJ, Forbes, M, Franzen, LA: Pilocarpine. Effect on the anterior chamber and lens thickness. Arch Ophthal 87:615, 1972.
Abramson, DH, Chang, S, Coleman, DJ, Smith, ME: Pilocarpine-induced lens changes. An ultrasonic biometric evaluation of dose response. Arch Ophthal 92:464, 1974.
Abramson, DH, Chang, S, Coleman, DJ: Pilocarpine therapy in glaucoma. Effects on anterior chamber depth and lens thickness in patients receiving long-term therapy. Arch Ophthal 94:914, 1976.
Pooinoosawmy, D, Nagasubramanian, S, Brown, NAP: Effect of pilocarpine on visual acuity and on the dimensions of the cornea and anterior chamber. Br J Ophthal 60:676, 1976.
Francois, J, Goes, F: Ultrasonographic study of the effect of different miotics on the eye components. Ophthalmologica 175:328, 1977.
Abramson, DH, Franzen, LA, Coleman, DJ: Pilocarpine in the presbyope. Demonstration of an effect on the anterior chamber and lens thickness. Arch Ophthal 89:100, 1973.
Pape, LG, Forbes, M: Retinal detachment and miotic therapy. Am J Ophthal 85:558, 1978.
Beasley, H, Fraunfelder, FT: Retinal detachments and topical ocular miotics. Ophthalmology 86:95, 1979.
Alpar, JJ: Miotics and retinal detachment: a survey and case report. Ann Ophthal 11:395, 1979.
Schuman, JS, Hersh, P, Kylstra, J: Vitreous hemorrhage associated with pilocarpine. Am J Ophthal 108:333, 1989.
Garlikov, RS, Chenoweth, RG: Macular hole following topical pilocarpine. Ann Ophthal 7:1313, 1975.
Levene, RZ: Uniocular miotic therapy. Trans Am Acad Ophthal Otol 79:376, 1975.
Coles, WH: Pilocarpine toxicity. Effects on the rabbit corneal endothelium. Arch Ophthal 93:36, 1975.
Kennedy, RE, Roca, PD, Landers, PH: Atypical band keratopathy in glaucomatous patients. Am J Ophthal 72:917, 1971.
Brazier, DJ, Hitchings, RA: Atypical band keratopathy following long-term pilocarpine treatment. Br J Ophthal 73:294, 1989.
Kennedy, RE, Roca, PD, Platt, DS: Further observations on atypical band keratopathy in glaucoma patients. Trans Am Ophthal Soc LXXII:107, 1974.
Tauber, J, Melamed, S, Foster, CS: Glaucoma in patients with ocular cicatricial pemphigoid. Ophthalmology 96:33, 1989.
Fiore, PM, Jacobs, IH, Goldbert, DB: Drug-induced pemphigoid. A spectrum of diseases. Arch Ophthal 105:1660, 1987.
O’Brein, CS, Swan, KD: Carbaminoylcholine chloride in the treatment of glaucoma simplex. Arch Ophthal 27:253, 1942.
Smolen, VF, Clevenger, JM, Williams, EJ, Bergdolt, MW: Biophasic availability of ophthalmic carbachol I: Mechanisms of cationic polymer- and surfactant-promoted miotic activity. J Pharm Sci 62:958, 1973.
Reichert, RW, Shields, MB, Stewart, WC: Intraocular pressure response to replacing pilocarpine with carbachol. Am J Ophthal 106:747, 1988.
Hung, PT, Hsieh, JW, Chiou, GCY: Ocular hypotensive effects of N-demethylated carbachol on open angle glaucoma. Arch Ophthal 100:262, 1982.
Ruiz, RS, Rhem, MN, Prager, TC: Effects of carbachol and acetylcholine on intraocular pressure after cataract extraction. Am J Ophthal 107:7, 1989.
Linn, DK, Zimmerman, TJ, Nardin, GF, et al: Effect of intracameral carbachol on intraocular pressure after cataract extraction. Am J Ophthal 107:133, 1989.
Wood, TO: Effect of carbachol on postoperative intraocular pressure. J Cat Ref Surg 14:654, 1988.
Birnbaum, DB, Hull, DS, Green, K, Frey, NP: Effect of carbachol on rabbit corneal endothelium. Arch Ophthal 105:253, 1987.
Zimmerman, TJ, Dukar, U, Nardin, GF, et al: Carbachol dose response. Am J Ophthal 108:456,1989.
Fechner, PU, Teichmann, KD, Weyrauch, W: Accommodative effects of aceclidine in the treatment of glaucoma. Am J Ophthal 79:104, 1975.
Drance, SM, Fairclough, M, Schulzer, M: Dose response of human intraocular pressure to aceclidine. Arch Ophthal 88:394, 1972.
Riegel, D, Leydhecker, W: Experiences with aceclidine in the treatment of simple glaucoma. Klin Monatsbl Augenheilkd 151:882, 1967.
Fechner, PU: Avoiding spasm of accommodation in the treatment of young glaucoma patients. Klin Monatsbl Augenheilkd 158:112, 1971.
Pilz, A, Lommatzsch, P, Ulrich, W-D: Experimentelle und klinsche Untersuchungen mit Aceclidin (Glaucostat). Ophthalmologica 168:376, 1974.
Erickson-Lamy, K, Schroeder, A: Dissociation between the effect of aceclidine on outflow facility and accommodation. Exp Eye Res 50:143, 1990.
Leopold, IH, Furman, M: Cholinesterase isoenzymes in human ocular tissue homogenates. Am J Ophthal 72:460, 1971.
Juul, P: Human plasma cholinesterase isoenzymes. Clin Chim Acta 19:205, 1968.
Harris, LS, Shimmyno, M, Mittag, TW: Cholinesterases and contractility of cat irides. Effect of echothiophate iodide. Arch Ophthal 89:49, 1973.
Harris, LS, Shimmyno, M, Mittag, TW: Effects of echothiophate on cholinesterases in cat irides. Arch Ophthal 91:57, 1974.
Lütjen-Drecoll, E, Kaufman, PL: Biomechanics of echothiophate-induced anatomic changes in monkey aqueous outflow system. Graefe’s Arch Ophthal 224:564, 1986.
Harris, LS, Shimmyno, M, Hughes, J: Dose-response of cholinergic agonists on cat irides. Arch Ophthal 91:299, 1974.
Harris, LS: Dose-response analysis of echothiophate iodide. Arch Ophthal 86:502, 1971.
Reichert, RW, Shields, MB: Intraocular pressure response to replacing pilocarpine or carbachol with echothiophate iodide. Graefe’s Arch Ophthal 229:252, 1991.
Ellis, PP, Esterdahl, M: Echothiophate iodide therapy in children. Effect upon blood cholinesterase levels. Arch Ophthal 77:598, 1967.
Birks, DA, Prior, VJ, Silk, E, Whittaker, M: Echothiophate iodide treatment of glaucoma in pregnancy. Arch Ophthal 79:283, 1968.
Ellis, PP, Littlejohn, K: Effects of topical anticholinesterases on procaine hydrolysis. Am J Ophthal 77:71, 1974.
Wood, JR, Anderson, RL, Edwards, JJ: Phospholine iodide toxicity and Jones’ tubes. Ophthalmology 87:346, 1980.
Dressel, TD, Goodale, RL, Arneson, MA, Borner, JW: Pancreatitis as a complication of anticholinesterase insecticide intoxication. Ann Surg 189:199, 1979.
Friberg, TR, Thomas, JV, Dressel, TD: Serum cholinesterase, serum lipase, and serum amylase levels during longterm echothiophate iodide therapy. Am J Ophthal 91:530, 1981.
Lipson, ML, Holmes, JH, Ellis, PP: Oral administration of pralidoxime chloride in echothiophate iodide therapy. Arch Ophthal 82:830, 1969.
Axelsson, U, Holmberg, Å: The frequency of cataract after miotic therapy. Acta Ophthal 44:421, 1966.
Axelsson, U: Studies on echothiophate (phospholine iodide) and paraoxon (mintacol) with regard to cataractogenic effect. Acta Ophthal (suppl) 102, 1969.
Thoft, RA: Incidence of lens changes in patients treated with echothiophate iodide. Arch Ophthal 80:317, 1968.
Pietsch, RL, Bobo, CB, Finklea, JF, Vallotton, WW: Lens opacities and organophosphate cholinesterase-inhibiting agents. Am J Ophthal 73:236, 1973.
Kaufman, PL, Axelsson, U: Induction of subcapsular cataracts in aniridic vervet monkeys by echothiophate. Invest Ophthal 14:863, 1975.
Kaufman, PL, Axelsson, U, Bárány, E: Induction of subcapsular cataracts in cynomolgus monkeys by echothiophate. Arch Ophthal 95:499, 1977.
Albrecht, M, Bárány, E: Early lens changes in Macaca fascicularis monkeys under topical treatment with echothiophate or carbachol studied by slit-image photography. Invest Ophthal Vis Sci 18:179, 1979.
Philipson, B, Kaufman, PL, Fagerholm, P, et al: Echothiophate cataracts in monkeys. Electron microscopy and microradiography. Arch Ophthal 97:340, 1979.
Michon, J Jr, Kinoshita, JH: Experimental miotic cataract. II. Permeability, cation transport, and intermediary metabolism. Arch Ophthal 79:611, 1968.
Lazar, M, Nowakowski, J, Furman, M, Shore, B: Ocular penetration of topically applied mannitol. Am J Ophthal 70:849, 1970.
Kaufman, PL, Axelsson, U, Bárány, EH: Atropine inhibition of echothiophate cataractogenesis in monkeys. Arch Ophthal 95:1262, 1977.
Kaufman, PL, Erickson, KA, Neider, MW: Echothiophate iodide cataracts in monkeys. Occurrence despite loss of accommodation induced by retrodisplacement of ciliary muscle. Arch Ophthal 101:125, 1983.
Lütjen-Drecoll, E, Kaufman, PL: Echothiophate-induced structural alterations in the anterior chamber angle of the cynomolgus monkey. Invest Ophthal Vis Sci 18:918, 1979.
Patten, JT, Cavanagh, HD, Allansmith, MR: Induced ocular pseudopemphigoid. Am J Ophthal 82:272, 1976.
Mathias, CGT, Maibach, HI, Irvine, A, Adler, W: Allergic contact dermatitis to echothiophate iodide and phenylephrine. Arch Ophthal 97:286, 1979.
Krejci, L, Harrison, R: Antiglaucoma drug effects on corneal epithelium. A comparative study in tissue culture. Arch Ophthal 84:766, 1970.
Grant, WM: Miotic and antiglaucomatous activity of tetraethyl pyrophosphate in human eyes. Arch Ophthal 39:579, 1948.
Grant, WM: Additional experiences with tetraethyl pyrophosphate in treatment of glaucoma. Arch Ophthal 44:362, 1950.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Shields, M.B., Krieglstein, G.K. (1993). Parasympathomimetika. In: Glaukom. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77053-1_25
Download citation
DOI: https://doi.org/10.1007/978-3-642-77053-1_25
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-77054-8
Online ISBN: 978-3-642-77053-1
eBook Packages: Springer Book Archive